Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hematopoietic growth factors].

H Zwierzina1, S Hoffmann, F Schmalzl

  • 1Medizinischen Klinik Innsbruck.

Wiener Medizinische Wochenschrift (1946)
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Growth-inhibitory effect of 2-CdA on myeloid CFU-GM progenitors in normal human long-term bone marrow cultures and its compensation by G-CSF or IL-3.

Experimental hematology·1995
Same author

Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency.

Journal of hepatology·1994
Same author

Alpha-1-antitrypsin deficiency and liver disease.

Digestive diseases (Basel, Switzerland)·1994
Same author

Causes of liver disease in an adult population with heterozygous and homozygous alpha 1-antitrypsin deficiency.

Acta paediatrica (Oslo, Norway : 1992). Supplement·1994
Same author

The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake.

Blood·1994
Same author

[Prognosis and life expectancy in primary biliary cirrhosis].

Wiener klinische Wochenschrift·1994

Hematopoietic growth factors, also known as colony-stimulating factors (CSFs), are key cytokines for immune and blood cell signaling. Recombinant CSFs offer new therapeutic strategies with manageable side effects in clinical trials.

Area of Science:

  • Hematopoietic growth factors (HGFs) are a class of cytokines.
  • Also known as colony-stimulating factors (CSFs), they regulate blood cell development.

Context:

  • HGFs are glycoproteins produced by various cells.
  • They signal within hematopoietic and immune systems, alone or by inducing other cytokines.
  • Recent gene cloning enables large-scale recombinant factor production for clinical use.

Purpose:

  • To explore the clinical applications of hematopoietic growth factors.
  • To provide insights into early clinical trial results and future therapeutic possibilities.
  • To highlight the potential of cytokines in modulating physiological processes for novel therapies.

Summary:

  • Recombinant HGFs are being investigated for therapeutic potential.
  • Clinical trials show encouraging results with tolerable, dose-dependent side effects.

Related Experiment Videos

  • This biological therapy contrasts with cytotoxic regimens, aiming for minimal effective doses.

    • Impact:

    • Cytokines, including HGFs, enable new therapeutic concepts by modulating the body's own processes.
    • Early clinical data suggests HGFs are well-tolerated and effective.
    • The development of recombinant factors opens avenues for innovative medical treatments.